Dr
Alex
Colman

Senior European Patent Attorney

Manchester Office

Engineering

Telephone. +44(0) 161 247 4900
Email. [email protected]

Experience

Alex is pragmatic and straight-talking. Whether working with in-house counsel at large corporates or first-time patent applicants, he garners praise for guiding clients through the complexities of patent issues to achieve solutions most useful to their businesses. He has expertise in delivering great value advise, having made a speciality of helping clients with tight margins and those in the early stages of commercialising their ideas.

His colleagues describe him as a safe pair of hands, which is why Alex handles matters for some of HGF’s largest clients, and helps to develop its commercial relationships. Clients benefit from his creative ability to revitalise the fortunes of the most struggling patent applications before both the UK Intellectual Property Office and the European Patent Office.

While Alex has successfully prepared and prosecuted patent applications in wide variety of subject-matter in the field of mechanical engineering, he is focused primarily on building technologies and construction products, medical devices, automotive and aerospace technologies and textiles. Alex’s practice is not limited to prosecution work, as he regularly advises on infringement and validity matters, and is building a winning record of oppositions and appeals.

Alex came to HGF from Newcastle University, where he gained a first-class Master’s degree in civil and structural engineering, and a PhD in structural engineering.

Qualifications

Patent Attorney

European


MENG

Civil and Structural Engineering

PHD

Structural Engineering

Publications

Coronavirus update: Oral proceedings before Opposition Divisions and Boards of Appeal

View publication online

Related News

Patentability of Simulations in Europe

Simulations offer a powerful tool in modern-day engineering. Subjecting designs to initial testing in a simulated environment will, for many designs, reduce costs owing to reduced needs to produce and …

Read article

Blockbuster blood thinning patent revoked

Summary Mr Justice Meade has revoked Bristol Myers Squibb’s (BMS) European patent No. EP1427415 (EP’415) and corresponding supplementary protection certificate (SPC) that relate to the compound Apixaban (ELIQUIS) for lack …

Read article
Event - 10th May 2022

The HGF IP in Healthcare Conference 2022

After a challenging couple of years, we are delighted to invite you to join us for HGF’s eighth annual IP in Healthcare Conference. We will review the latest intellectual property …

Event details
Event - 10th May 2022

HGF UPC events in Germany and Austria 2022

HGF is holding a webinar and an in-person event covering the UPC in Germany and Austria this Spring. The provisional phase of the Unified Patent Court (UPC) is now underway …

Event details
Event - 23rd March 2022

HGF webinar: Getting your first filing right

HGF hosted a webinar on Wednesday 23rd March on Getting your first filing right. One of the most often asked questions of patent attorneys is: “when should we file?” Both …

Event details
Event - 10th March 2022

Manufacturing & Supply Chain Conference 2022

HGF Patent Attorney Dr Robert Weinert-Aplin is attending and speaking at the Manufacturing & Supply Chain Conference on 10th March 2022 in Milton Keynes, UK. The Manufacturing & Supply Chain …

Event details

The Microbiome Times: ELIGO v SNIPR: a reflection on IP strategies in a competitive environment

HGF Partner and Patent Attorney Craig Thomson and Patent Director Dr Jennifer Bailey write an article for The Microbiome Times on ELIGO v SNIPR: a reflection on IP strategies in …

Read article

UPC could open its doors in 2022

With news that the Austrian parliament has ratified the Protocol on the provisional application of the Agreement on a Unified Patent Court on 2 December 2021, the Unified Patent Court …

Read article

Let's talk

If you would like to discuss how HGF could help you, contact one of our IP specialists.